Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 216574

In scope icon M 11
QID 216574 (Type "216574" in App Search)
A 54-year-old woman presents with worsening abdominal pain and vaginal bleeding. The patient underwent menarche at age 12 and menopause at age 51. However, around 5 months ago, she began noticing intermittent spotting in her underwear. This has been accompanied by episodes of cramping abdominal pain that are increasing in frequency. Her past medical history is significant for hypertension and gastroesophageal reflux disease for which she takes lisinopril and omeprazole. She does not smoke tobacco, drink alcohol, or use illicit drugs. Her temperature is 98.6°F (37°C), blood pressure is 115/80 mmHg, pulse is 75/min, and respirations are 12/min. Physical exam is significant for tenderness to palpation in the left lower abdomen and a left adnexal mass. Laboratory evaluation is performed and shows:

Anti-mullerian hormone (AMH): 190 ng/mL (normal < 1 ng/mL)
Inhibin A: 720 pg/mL (normal < 5 pg/mL)

Transvaginal ultrasound examination shows an 8 cm left adnexal mass and a 5 mm endometrial stripe. Which of the following is the most appropriate next step in management?

Anastrozole

0%

0/0

Endometrial biopsy

0%

0/0

Neoadjuvant chemotherapy

0%

0/0

Ovarian biopsy

0%

0/0

Unilateral salpingo-oophorectomy

0%

0/0

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient with abdominal pain, postmenopausal vaginal bleeding, left adnexal mass, elevated anti-mullerian hormone, elevated inhibin A, and an enlarged endometrial stripe likely has a granulosa cell tumor (GCT). The evaluation of GCTs should include endometrial biopsy in order to guide management.

GCTs are the most common type of gonadal stromal cell tumor, an unusual group of functional (hormone-producing) ovarian tumors. GCTs may secrete large amounts of estrogen that can cause endometrial hyperplasia or carcinoma in older women. Hyperestrogenism is likely in women with a suspected GCT and abnormal uterine bleeding (in all women) or a thickened endometrial stripe (in postmenopausal women only). Endometrial sampling should be performed in all GCT patients with hyperestrogenism in order to guide further management. Younger patients without evidence of endometrial involvement can be treated with unilateral oophorectomy and careful staging in order to preserve fertility. However, in postmenopausal patients or patients with evidence of endometrial involvement, bilateral salpingo-oophorectomy and hysterectomy should be performed.

Schumer et al. review the epidemiology, risk factors, diagnosis, pathologic features, tumor markers, and management of granulosa cell tumors. The authors find that the survival of patients with GCT is generally excellent as most patients present with early-stage disease. However, the authors still recommend prolonged surveillance after treatment with serial physical examination and serum tumor markers (estradiol and inhibin) in patients with GCT.

Incorrect Answers:
Answer 1: Anastrozole is an aromatase inhibitor that suppresses estrogen production from adipose tissues. Anastrozole is used as adjuvant endocrine therapy in postmenopausal patients with hormone-receptor-positive (ER-positive or PR-positive) breast cancer. However, anastrozole would not suppress estrogen production from GCTs.

Answer 3: Neoadjuvant chemotherapy is the use of chemotherapy to reduce the size of a tumor prior to surgery. Neoadjuvant chemotherapy with bevacizumab has been studied in GCT, but it has not been shown to improve outcomes.

Answer 4: Ovarian biopsy is contraindicated when a malignant neoplasm is suspected. Ovarian biopsies may result in the seeding of neoplastic cells along the biopsy tract.

Answer 5: Unilateral salpingo-oophorectomy is an option for treating premenopausal women with GCT. However, in all cases, an endometrial biopsy must be done in order to rule out endometrial hyperplasia or carcinoma which would require a bilateral salpingo-oophorectomy with hysterectomy. In this postmenopausal patient with signs of hyperestrogenism, an endometrial biopsy should be done first.

Bullet Summary:
Endometrial biopsy should be performed in the evaluation of patients with granulosa cell tumors (GCTs) as hyperestrogenism from these tumors can increase the risk of endometrial cancer.

REFERENCES (1)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options